The gray market's biggest name just closed. A physician-authored guide to understanding what happened, which compounds are still legally accessible, and how to transition to a regulated, physician-supervised protocol.
Peptide Sciences didn't get raided. They read the regulatory trajectory, counted their earnings, and made a rational business decision. Understanding why they left tells you everything about what comes next for gray market sourcing.
"The FDA isn't killing peptides. They're killing the gray market distribution channel. The molecules aren't going away. The unregulated vendors selling them without oversight or accountability are."
The picture is more nuanced than most coverage suggests. A meaningful portfolio remains accessible through a physician prescription and a licensed compounding pharmacy.
7 pages. Written by Dr. Yusuf Mathai, MD/MPH. Covers the full regulatory story, compound-by-compound availability, gray market vs. prescribed comparison, and your specific next steps.
Call us directly: (503) 506-8500 • [email protected]
Oregon Health DPC was designed for patients who take their health seriously, have done their research, and want clinical depth — not a 10-minute prescription renewal from a telehealth mill.
Our approach to peptide and optimization programs begins with a comprehensive baseline evaluation, follows with a physician-designed protocol built around your specific biology, and includes regular monitoring to verify clinical response. All compounds are dispensed from an FDA-registered compounding pharmacy with batch certificates of analysis.
If you are looking for an anonymous online checkout and a generic protocol, we are not the right fit. If you want a physician who will understand your history and build a protocol around your goals, we should talk.
Schedule a Private Assessment